Kliniska studier för Gliom i Colorado
11 studier för Gliom söker deltagare vid platser i Colorado.
Städer i Colorado
Officiell studietext (engelska)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospital Colorado, Aurora
RekryterarFas 1/2
12 Months – 21 Years · Alla kön · Uppdaterad 1 okt. 2026 · NCT05099003A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Colorado - Anschutz Medical Campus, Aurora
RekryterarFas 1/2
Upp till ålder 25 · Alla kön · Uppdaterad 25 sep. 2026 · NCT04094610ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Children's Hospital Colorado, Aurora
RekryterarFas 2
12 Months – 39 Years · Alla kön · Uppdaterad 21 sep. 2026 · NCT06838676Targeted Pediatric High-Grade Glioma Therapy
- Children's Hospital Colorado, Aurora
RekryterarObservationsstudie
12 Months – 39 Years · Alla kön · Uppdaterad 8 sep. 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Children's Hospital Colorado, Aurora
RekryterarFas 2
Ålder 12 till 39 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Colorado Health Cancer Care, Aurora
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Children's Hospital Colorado, Aurora
RekryterarFas 2
Ålder 3 till 39 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05096481Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's Hospital Colorado, Aurora
RekryterarTidig fas 1Friska volontärer välkomna
Ålder 1 till 21 · Alla kön · Uppdaterad 29 juni 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's Hospital Colorado, Aurora
RekryterarFas 2
12 Months – 39 Years · Alla kön · Uppdaterad 29 maj 2026 · NCT05843253A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- Sarah Cannon Research Institute at Health ONE, Denver
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 20 apr. 2026 · NCT06326411A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Children's Hospital Colorado, Aurora
RekryterarTidig fas 1
Upp till ålder 21 · Alla kön · Uppdaterad 18 mars 2026 · NCT04655404Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.